Oligoastrocytoma pathophysiology: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 15: | Line 15: | ||
:*[[translocation|t(1;19)(q10;p10)]] | :*[[translocation|t(1;19)(q10;p10)]] | ||
:*''[[p53]]'' | :*''[[p53]]'' | ||
:*''[[ATRX]]'' | |||
===Gross Pathology=== | ===Gross Pathology=== | ||
Revision as of 15:23, 16 October 2015
|
Oligoastrocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Oligoastrocytoma pathophysiology On the Web |
|
American Roentgen Ray Society Images of Oligoastrocytoma pathophysiology |
|
Risk calculators and risk factors for Oligoastrocytoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Pathophysiology
Pathogenesis
Genetics
- Development of oligoastrocytoma is the result of multiple genetic mutations.
- Oligoastrocytomas are mixed tumors that have overlapping molecular genetics with both oligodendrogliomas and astrocytomas.[1]
- Genes associated with the pathogenesis of oligoastrocytoma include:[1]
Gross Pathology
- On gross pathology, oligoastrocytoma is characterized by
Gallery
Microscopic Pathology
On microscopic histopathological analysis, oligoastrocytoma is characterized by:
On microscopic histopathological analysis, anaplastic oligoastrocytoma is characterized by:
Gallery
Immunohistochemistry
Oligoastrocytoma is demonstrated by positivity to tumor markers such as:[2]
References
- ↑ 1.0 1.1 Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J; et al. (2002). "Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets". Am J Pathol. 161 (1): 313–9. doi:10.1016/S0002-9440(10)64183-1. PMC 1850690. PMID 12107116.
- ↑ IHC of oligoastrocytoma. Librepathology 2015. http://librepathology.org/wiki/index.php/Oligoastrocytoma. Accessed on October 16, 2015